Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
Other Sizes |
|
ML-109 (CID-25246343) is a novel, potent and full thyroid stimulating hormone receptor (TSHR) agonist with an EC50 of 40 nM. This small-molecule TSHR agonist is the first to be available orally, and as such, it will serve as a valuable pharmacological tool for researching the biology of TSHR in thyroid and extrathyroidal tissues.
Targets |
TSHR ( EC50 = 40 nM )
|
---|---|
ln Vitro |
ML-109 (Compound 2) exhibits no activity at FSHR or LHCGR, similar to compound 1, and is a full agonist at TSHR with an EC50 of 40 nM. There is a functional group in ML-109 called an aminal that can be broken down by hydrolysis or other processes. It has been observed that ML-109 degrades at low pH (t1/2 of ~3 h), but it is surprisingly stable at neutral and basic conditions (t1/2 of ~16 h)[1].
|
References | |
Additional Infomation |
N-[4-[[5-[5-hydroxy-4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide is a member of quinazolines.
|
Molecular Formula |
C31H29N3O5
|
---|---|
Molecular Weight |
523.57906794548
|
Exact Mass |
523.21
|
Elemental Analysis |
C, 71.11; H, 5.58; N, 8.03; O, 15.28
|
CAS # |
1186649-91-1
|
Related CAS # |
ML109 HCl; 1186649-91-1
|
PubChem CID |
25246343
|
Appearance |
White to light yellow solid powder
|
LogP |
5.1
|
Hydrogen Bond Donor Count |
3
|
Hydrogen Bond Acceptor Count |
6
|
Rotatable Bond Count |
8
|
Heavy Atom Count |
39
|
Complexity |
812
|
Defined Atom Stereocenter Count |
0
|
InChi Key |
JRVXFGNCHKHBPA-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C31H29N3O5/c1-20(35)32-24-12-14-25(15-13-24)39-19-23-17-22(11-16-28(23)38-2)30-33-26-9-6-10-27(36)29(26)31(37)34(30)18-21-7-4-3-5-8-21/h3-17,30,33,36H,18-19H2,1-2H3,(H,32,35)
|
Chemical Name |
N-[4-[[5-(3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxyphenyl]methoxy]phenyl]acetamide
|
Synonyms |
ML-109; ML 109; ML109; CID-25246343; CID 25246343; CID25246343
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: ~83.3 mg/mL (~159.2 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.17 mg/mL (4.14 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 21.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.17 mg/mL (4.14 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 21.7 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.17 mg/mL (4.14 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.9099 mL | 9.5496 mL | 19.0993 mL | |
5 mM | 0.3820 mL | 1.9099 mL | 3.8199 mL | |
10 mM | 0.1910 mL | 0.9550 mL | 1.9099 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Compound 2 activates TSHR by binding to the transmembrane helical bundle. Proc Natl Acad Sci U S A . 2009 Jul 28;106(30):12471-6. td> |
Stimulation of the expression of the mRNAs for TG, TPO, NIS, and DIO2, and DIO2 protein by TSH or compound 2 in primary cultures of human thyrocytes. Proc Natl Acad Sci U S A . 2009 Jul 28;106(30):12471-6. td> |
Stimulation by compound 2 of thyroxine (T4) secretion and thyroidal radioiodide uptake in mice. Proc Natl Acad Sci U S A . 2009 Jul 28;106(30):12471-6. td> |